Franklin Street Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Franklin Street Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,280	Closed	-$393K	–	160
2018 Q2	$393K	Hold	2,280	–	–	0.06%	112
2018 Q1	$344K	Sell	2,280 -150	-6%	-$22K	0.05%	122
2017 Q4	$327K	Sell	2,430 -1,000	-29%	-$139K	0.05%	134
2017 Q3	$502K	Buy	+3,430	New	+$519K	0.08%	100
2017 Q1	–	Sell	-7,150	Closed	-$780K	–	168
2016 Q4	$780K	Hold	7,150	–	–	0.14%	105
2016 Q3	$869K	Hold	7,150	–	–	0.16%	105
2016 Q2	$1.01M	Hold	7,150	–	–	0.19%	103
2016 Q1	$933K	Hold	7,150	–	–	0.18%	109
2015 Q4	$1M	Hold	7,150	–	–	0.2%	115
2015 Q3	$950K	Hold	7,150	–	–	0.19%	116
2015 Q2	$1.26M	Hold	7,150	–	–	0.23%	105
2015 Q1	$1.24M	Hold	7,150	–	–	0.23%	104
2014 Q4	$1.17M	Hold	7,150	–	–	0.22%	102
2014 Q3	$1.15M	Hold	7,150	–	–	0.22%	103
2014 Q2	$1.05M	Hold	7,150	–	–	0.2%	113
2014 Q1	$992K	Sell	7,150 -42,405	-86%	-$6.38M	0.2%	113
2013 Q4	$6.27M	Sell	49,555 -14,120	-22%	-$1.46M	1.27%	24
2013 Q3	$5.86M	Sell	63,675 -1,710	-3%	-$138K	1.31%	21
2013 Q2	$4.49M	Buy	+65,385	New	+$4M	1.1%	27

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Franklin Street Advisors's JAZZ Position: Q3 2018 in Review

Franklin Street Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2018, closing a stake of 2,280 shares — an estimated $393K sold.

Franklin Street Advisors first reported a position in JAZZ in Q2 2013 and held it in 19 quarters. The position peaked at $6.27M in Q4 2013. 403 funds tracked by Wall St. Rank hold JAZZ as of Q3 2018.

Franklin Street Advisors reported no remaining Jazz Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Franklin Street Advisors sold 2,280 Jazz Pharmaceuticals shares in Q3 2018, an estimated $393K.
Franklin Street Advisors first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 19 quarters.
Franklin Street Advisors's Jazz Pharmaceuticals position peaked at $6.27M in Q4 2013.
403 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2018.

Based on Franklin Street Advisors's 13F filing for Q3 2018, filed 5 Oct 2018.